Natixis Advisors LLC Buys 1,058,617 Shares of Avantor, Inc. $AVTR

Natixis Advisors LLC grew its position in shares of Avantor, Inc. (NYSE:AVTR) by 124.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,907,077 shares of the company’s stock after purchasing an additional 1,058,617 shares during the period. Natixis Advisors LLC owned approximately 0.28% of Avantor worth $23,800,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. EverSource Wealth Advisors LLC boosted its stake in Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after buying an additional 1,189 shares during the last quarter. Strategic Wealth Investment Group LLC purchased a new position in Avantor during the 2nd quarter valued at approximately $32,000. Osaic Holdings Inc. increased its stake in Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after acquiring an additional 1,064 shares during the last quarter. Farther Finance Advisors LLC raised its holdings in shares of Avantor by 172.1% during the 3rd quarter. Farther Finance Advisors LLC now owns 3,709 shares of the company’s stock worth $46,000 after acquiring an additional 2,346 shares in the last quarter. Finally, Allworth Financial LP raised its holdings in shares of Avantor by 110.0% during the 2nd quarter. Allworth Financial LP now owns 3,740 shares of the company’s stock worth $50,000 after acquiring an additional 1,959 shares in the last quarter. 95.08% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on AVTR shares. Citigroup cut their target price on shares of Avantor from $13.00 to $11.00 and set a “neutral” rating for the company in a report on Thursday, February 12th. Stifel Nicolaus set a $10.00 price target on shares of Avantor in a research note on Thursday, February 12th. Wells Fargo & Company lowered their price objective on shares of Avantor from $16.00 to $14.00 and set an “overweight” rating for the company in a research report on Friday, February 13th. UBS Group reissued a “neutral” rating and issued a $10.50 price objective on shares of Avantor in a research note on Thursday, February 12th. Finally, Barclays restated an “underweight” rating and issued a $8.50 target price on shares of Avantor in a report on Friday, March 6th. Three equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $11.80.

Insider Transactions at Avantor

In other news, Director Gregory L. Summe purchased 100,000 shares of the company’s stock in a transaction that occurred on Thursday, February 12th. The stock was purchased at an average cost of $9.40 per share, with a total value of $940,000.00. Following the purchase, the director owned 400,000 shares in the company, valued at approximately $3,760,000. This trade represents a 33.33% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Gregory T. Lucier purchased 50,000 shares of the business’s stock in a transaction that occurred on Thursday, February 19th. The shares were purchased at an average price of $9.16 per share, for a total transaction of $458,000.00. Following the completion of the acquisition, the director directly owned 50,000 shares in the company, valued at $458,000. The trade was a ∞ increase in their position. The SEC filing for this purchase provides additional information. In the last quarter, insiders bought 275,000 shares of company stock worth $2,399,250. 1.20% of the stock is currently owned by insiders.

Avantor Stock Performance

NYSE AVTR opened at $8.32 on Thursday. The business’s 50 day moving average price is $10.51 and its 200-day moving average price is $11.75. Avantor, Inc. has a fifty-two week low of $7.82 and a fifty-two week high of $17.11. The company has a market cap of $5.68 billion, a P/E ratio of -10.67, a P/E/G ratio of 3.20 and a beta of 0.97. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.18 and a current ratio of 1.78.

Avantor (NYSE:AVTR) last issued its quarterly earnings results on Wednesday, February 11th. The company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.21 by $0.01. Avantor had a positive return on equity of 10.45% and a negative net margin of 8.09%.The company had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period last year, the company earned $0.27 earnings per share. Avantor’s revenue was down 1.4% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. Sell-side analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current year.

Avantor Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.